CASE STUDIES

Improving the outcomes that matter most — for your patients and your practice.

Read about the proven safety and efficacy of the CyberKnife® System for the treatment of trigeminal neuralgia.

Read about the safety and efficacy of CyberKnife SBRT for prostate cancer patients.

Read about the superior clinical outcomes when treating head and neck cancer with helical TomoTherapy® over RapidArc.
.

  • Product

  • Indications

Found 37 Results
Page 3 of 4

CASE STUDY

Para-Aortic Lymph Node Metastasis

The CyberKnife System provided a convenient and minimally invasive treatment option for patients with metastasis to para-aortic lymph nodes.


CASE STUDY

Optic Apparatus Meningioma

Treatment with CyberKnife radiosurgery utilizing a hypofractionated treatment regimen was indicated for maximum local control and to minimize injury to the optic apparatus.


CASE STUDY

Non-Small Cell Lung Cancer – Left Upper Lung

Three months after treatment, the patient reported no evidence of local regional recurrence or treatment-related toxicity.


CASE STUDY

Non-Invasive Treatment of Non-Small Cell Lung Cancer

This patient had an excellent initial outcome with the CyberKnife System using Xsight® Lung Tracking; the patient was able to undergo treatment without implanted fiducials or markers.


CASE STUDY

Left Optic Nerve Meningioma (WHO Grade 2)

Due to the risk of recurrence and intimate association of the lesion with the optic nerve, the CyberKnife® System was selected.


CASE STUDY

C5 Malignant Peripheral Nerve Sheath Tumor

There were no further treatment possibilities as surgery, conventional radiation therapy and chemotherapy were already attempted without preventing tumor growth.


CASE STUDY

T6 Spinal Solitary Breast Metastasis

The treatment of both malignant as well as benign tumors of the spine using CyberKnife radiosurgery began in 1997. Treatment of spine lesions using single fraction radiosurgery has been a successful treatment strategy at UPMC over the past four years.


CASE STUDY

Synchronous Bilateral Stage 1A Non-Small Cell Carcinoma

Patient was unwilling to undergo a second thoracotomy, and instead chose to receive CyberKnife® treatment of the lesion with concurrent chemotherapy.


CASE STUDY

Recurrent Ovarian Carcinoma

The CyberKnife System provided a convenient and minimally invasive treatment option for this patient with recurrent ovarian carcinoma who had failed previous surgery and chemotherapy.


CASE STUDY

Recurrent Nasopharyngeal Squamous Cell Carcinoma

Radiosurgery is a practical alternative for both boost therapy after external beam radiotherapy and salvage therapy in patients with recurrent NPC.


Start typing and press Enter to search

Send this to a friend